Work

In Vivo Mobilization of Multiple Myeloma Cells Out of the Bone Marrow Using the CXCR4 Inhibitor AMD3100 and Bortezomib: Implications for Sensitization of Myeloma Cells to Apoptosis.

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.2501.2501

Authors: Judith M. Runnels, Abdelkareem Azab, Costas Pitsillides, Anne-Sophie Moreau, Feda Azab, Joel A. Spencer, Xavier Leleu, Alicia L. Carlson, Beatriz E. Ospina, Renee Wright, Xiaoying Jia, Hai Ngo, Andrew L. Kung, Charles P. Lin, Irene M. Ghobrial

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2986115437

FWCI: 0.568

Cites:

Cited by: 3

Related to: 10